<DOC>
	<DOCNO>NCT00677144</DOCNO>
	<brief_summary>The aim study compare activity safety Oxaliplatin S-1 ( OS ) Oxaliplatin Capecitabine ( XELOX ) patient advance recurrent colorectal cancer .</brief_summary>
	<brief_title>Oxaliplatin S-1 ( OS ) Versus Oxaliplatin Capecitabine ( XELOX ) Advanced Colorectal Cancer</brief_title>
	<detailed_description>Oxaliplatin oral fluoropyrimidines ( capecitabine S-1 ) active agent colorectal cancer . Recent phase II trial combination chemotherapy oxaliplatin S-1 ( OS ) several phase II trial combination chemotherapy oxaliplatin capecitabine ( XELOX ) demonstrate good activity mild toxicity advanced colorectal cancer . Oxaliplatin S-1 capecitabine distinct mechanisms action overlap key toxicity . Furthermore , oxaliplatin fluorouracil show highly synergistic , preclinical model also subsequent clinical trial .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Histologically confirm colorectal adenocarcinoma , initially diagnose recur Unresectable , locally advanced metastatic At least one unidimensional measurable lesion RECIST criterion Age 18 75 year old Estimated life expectancy ≥3 month ECOG performance status ≤2 Adequate bone marrow function ( WBCs ≥ 4,000/µL absolute neutrophil count ≥ 1,500/µL , platelet ≥ 100,000/µL ) Adequate kidney function ( creatinine &lt; 1.5 mg/dL ) Adequate liver function ( bilirubin &lt; 2.0 mg/dL , transaminase level &lt; 2.5 time upper normal limit ) Written inform consent Other tumor type adenocarcinoma Previous history chemotherapy ( exception : neoadjuvant adjuvant chemotherapy without oxaliplatin ) Presence CNS metastasis , psychosis , seizure Obvious bowel obstruction Evidence serious gastrointestinal bleeding Past concurrent history neoplasm colorectal adenocarcinoma , except curatively treat nonmelanoma skin cancer situ carcinoma cervix uteri Pregnant lactate woman , woman childbearing potential employ adequate contraception Other serious illness medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Colorectal Neoplasm</keyword>
	<keyword>S-1</keyword>
	<keyword>Capecitabine</keyword>
	<keyword>Oxaliplatin</keyword>
</DOC>